Sophia Genetics Sa (SOPH)

Überblick Nachrichten Preisverlauf Optionskette Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Sophia Genetics Sa Stock (SOPH) Company Profile

Sophia Genetics Sa

Healthcare (1113)

Nächster Verdiensttermin

Neueste SEC-Einreichungen

SOPH's Discussions on Twitter

Compare SOPH vs VEEV, TEM, BTSG, HQY, WAY

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
SOPH Sophia Genetics Sa	4.97	356.19M	77.27M	-79.00M	-48.46M	-1.1694
VEEV Veeva Systems Inc	179.11	29.44B	3.20B	908.91M	1.39B	5.4168
TEM Tempus Ai Inc	48.83	8.73B	1.27B	-245.03M	-245.36M	-1.4071
BTSG Brightspring Health Services Inc	43.31	8.32B	12.91B	104.80M	394.69M	0.8769
HQY Healthequity Inc	82.10	6.94B	1.31B	215.20M	408.32M	2.4627
WAY Waystar Holding Corp	24.03	4.61B	1.10B	112.09M	283.19M	0.6096

Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-12-18	Eingeleitet	Craig Hallum	Buy
2024-08-07	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2024-06-27	Eingeleitet	Guggenheim	Buy
2023-11-29	Eingeleitet	RBC Capital Mkts	Outperform
2023-07-05	Fortgesetzt	JP Morgan	Overweight
2023-01-03	Eingeleitet	BTIG Research	Buy
2022-11-23	Eingeleitet	Credit Suisse	Neutral
2021-10-15	Fortgesetzt	Cowen	Outperform
2021-08-17	Eingeleitet	Cowen	Outperform
2021-08-17	Eingeleitet	Credit Suisse	Outperform
2021-08-17	Eingeleitet	JP Morgan	Overweight
2021-08-17	Eingeleitet	Morgan Stanley	Overweight

Alle ansehen

Sophia Genetics Sa Aktie (SOPH) Neueste Nachrichten

Finanzdaten der Sophia Genetics Sa-Aktie (SOPH)

Sophia Genetics Sa (SOPH)

Sophia Genetics Sa Stock (SOPH) Company Profile

Compare SOPH vs VEEV, TEM, BTSG, HQY, WAY

Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades

Sophia Genetics Sa Aktie (SOPH) Neueste Nachrichten

SOPHiA GENETICS (NASDAQ:SOPH) CEO Sells $21,398.22 in Stock - Defense World

SOPH SEC FilingsSophia Genetics Sa 10-K, 10-Q, 8-K Forms - Stock Titan

SOPHiA GENETICS (NASDAQ:SOPH) CEO Jurgi Camblong Sells 4,486 Shares - MarketBeat

Form 144 SOPHiA GENETICS SA For: 19 March - Investing.com

Market Outlook: Is SOPHiA GENETICS SA a momentum stock2026 Earnings Surprises & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn

ZHENYU XU sells shares under 10b5-1 plan (SOPH) - Stock Titan

Restricted Stock Units Sale Notice (SOPH) — 10b5-1 Transactions Listed - Stock Titan

1,183 RSUs Listed for Sale by SOPH Insider (NASDAQ: SOPH) - Stock Titan

Proposed sale of 774 Restricted Stock Units (SOPH) reported in Form 144 - Stock Titan

Morgan Stanley Smith Barney LLC (NASDAQ: SOPH) files Form 144 for 608 RSUs - Stock Titan

Manuela Valente 10b5-1 sales reported for SOPH (SOPH) - Stock Titan

[144] SOPHiA GENETICS SA SEC Filing - Stock Titan

Form 144 SOPHiA GENETICS SA For: 19 March By Investing.com - Investing.com Canada

Jurgi Camblong (SOPH) reports multiple 10b5-1 sales across late 2025–2026 - Stock Titan

Trend Report: Can SOPHiA GENETICS SA continue delivering strong returns2026 Risk Factors & Stock Portfolio Risk Management - baoquankhu1.vn

Growth Recap: Why is SOPHiA GENETICS SA stock going downTake Profit & Accurate Entry/Exit Alerts - baoquankhu1.vn

SOPHiA GENETICS SA (NASDAQ:SOPH) Sees Significant Decrease in Short Interest - MarketBeat

[EFFECT] SOPHiA GENETICS SA SEC Filing - Stock Titan

Sophia Genetics Earnings Call: Growth Surges, Losses Linger - TipRanks

Aug PreEarnings: Can SOPHiA GENETICS SA stock double in the next yearJuly 2025 Momentum & High Yield Equity Trading Tips - baoquankhu1.vn

SOPHiA GENETICS (SOPH) Q4 Loss Deepens And Reinforces Bearish Profitability Concerns - Sahm

Will SOPHiA GENETICS SA stock go up in YEARQuarterly Trade Report & Technical Entry and Exit Alerts - baoquankhu1.vn

SOPHiA GENETICS Q4 Earnings Call Highlights - Defense World

Sophia Genetics SA (SOPH) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada

SOPHiA GENETICS S.A. (NASDAQ:SOPH) Q4 2025 Earnings Call Transcript - Insider Monkey

BTIG reiterates Sophia Genetics stock rating on customer growth - Investing.com South Africa

BTIG Maintains Buy on SOPHiA GENETICS S.A. (SOPH) March 03, 2026 - Meyka

SOPHiA GENETICS (NASDAQ: SOPH) registers 75,000 warrant shares for resale - Stock Titan

Fulgent Genetics (FLGT) Earnings Transcript - AOL.com

SOPHiA GENETICS S.A. Q4 2025 Earnings Call Summary - Yahoo Finance

SOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2025 on March 3, 2026 - Finviz

SOPHiA GENETICS (SOPH) Q4 2025 Earnings Transcript - The Globe and Mail

SOPHiA GENETICS SA reports results for the quarter ended December 31Earnings Summary - TradingView

SOPHiA GENETICS SA 2025 Q4ResultsEarnings Call Presentation (NASDAQ:SOPH) 2026-03-03 - Seeking Alpha

SOPHiA GENETICS (NASDAQ:SOPH) Posts Quarterly Earnings Results, Misses Estimates By $0.08 EPS - MarketBeat

Sophia Genetics reports fourth quarter and full year 2025 results - marketscreener.com

SOPHiA GENETICS (SOPH) 2025 20-F flags losses, platform and regulatory risks - Stock Titan

[6-K] SOPHiA GENETICS SA Current Report (Foreign Issuer) | SOPH SEC FilingForm 6-K - Stock Titan

Sophia Genetics Q4 Earnings Summary & Key TakeawaysSophia Genetics (NASDAQ:SOPH) - Benzinga

SOPHiA GENETICS Reports Fourth Quarter and Full Year 2025 Results - PR Newswire

A Look at Sophia Genetics's Upcoming Earnings ReportSophia Genetics (NASDAQ:SOPH) - Benzinga

SOPHiA GENETICS (SOPH) to Release Earnings on Tuesday - Defense World

SOPH Should I Buy - Intellectia AI

SOPHiA GENETICS SA expected to post a loss of 24 cents a shareEarnings Preview - TradingView

Short Interest in SOPHiA GENETICS SA (NASDAQ:SOPH) Expands By 194.3% - MarketBeat

Why The SOPHiA GENETICS (SOPH) Narrative Is Shifting On Richer Valuation And Growth Expectations - Yahoo Finance UK

SOPHiA GENETICS to Present at the 46th Annual TD Cowen Health Care Conference - Finviz

SOPHiA GENETICS CEO, president in TD Cowen fireside chat March 4 - Stock Titan

SOPHiA GENETICS (SOPH) Projected to Announce Earnings on Tuesday - MarketBeat

Zhenyu Xu files Rule 144 for SOPH (NASDAQ: SOPH) citing multiple 10b5-1 sales - Stock Titan

Cogent Biosciences Stock Soars 346% in a Year, but One Fund Just Sold Off $4.5 Million - AOL.com

Finanzdaten der Sophia Genetics Sa-Aktie (SOPH)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie SOPH